Presence of Chlamydia pneumoniae in patients with and without atherosclerosis

European Journal of Clinical Microbiology and Infectious Diseases

Volumn 24, Issue 8, 2005, Pages 507-513

  Podsiadly E ^a   Przyluski J ^b   Kwiatkowski, A ^c   Kruk, M ^b   Wszola M ^c   Nosek, R ^c   Rowinski W ^c   Ruzyllo W ^b   Tylewska Wierzbanowska, S ^a  

^a NATIONAL INSTITUTE OF HYGIENE   (Poland)

^b INSTITUTE OF CARDIOLOGY   (Poland)

^c MEDICAL UNIVERSITY OF WARSAW   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN A; IMMUNOGLOBULIN G;

ADULT; ANTIBODY SPECIFICITY; ARTICLE; ATHERECTOMY; ATHEROMA; ATHEROSCLEROSIS; BACTERIAL INFECTION; BLOOD ANALYSIS; CHLAMYDOPHILA PNEUMONIAE; CONTROLLED STUDY; DNA DETERMINATION; EVALUATION; HUMAN; LEUKOCYTE; MAJOR CLINICAL STUDY; PREVALENCE; PRIORITY JOURNAL; REVASCULARIZATION; SEROLOGY;

ADULT; AGED; ANTIBODIES, BACTERIAL; ARTERIOSCLEROSIS; CAROTID ARTERIES; CHLAMYDIA INFECTIONS; CHLAMYDOPHILA PNEUMONIAE; DNA, BACTERIAL; FEMALE; HUMANS; LEUKOCYTES; MALE; MIDDLE AGED;

EID: 26244452618     PISSN: 09349723     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10096-005-1380-0     Document Type: Article

References (47)

1. Siscovick DS, Schwartz SM, Caps M, Wang SP, Grayston JT (2000) Chlamydia pneumoniae and atherosclerotic risk in populations: the role of seroepidemiology. J Infect Dis 181(Suppl 3):S417-S420
2. Berkow R, Fletcher AJ (1995) MSD manual of diagnosis and therapy. Urban & Partner, Wroclaw, p 462
3. Banach M, Markuszewski L, Zaslonka J, Grzegorczyk J, Okonski P, Jegier B (2004) The role of infection in the pathogenesis of atherosclerosis. Przegl Epidemiol 58:671-676
4. Mayr M, Kiechl S, Willeit J, Wick G, Xu Q (2000) Associations of antibodies to Chlamydia pneumoniae, Helicobacter pylori, and cytomegalovirus with immune reactions to heat-shock protein 60 and carotid or femoral atherosclerosis. Circulation 102:833-839
5. Stintzing S, Heuschmann P, Barbera L, Ocker M, Jung A, Kirchner T, Neureiter D (2005) Overexpression of MMP9 and tissue factor in unstable carotid plaques associated with Chlamydia pneumoniae, inflammation and apoptosis. Ann Vasc Surg 19:310-319
6. Grahame-Clarke C, Chan NN, Andrew D, Ridgway GL, Betteridge DJ, Emery V, Colhoun HM, Vallance P (2003) Human cytomegalovirus seropositivity is associated with impaired vascular function. Circulation 108:678-683
7. Latsios G, Saetta A, Michalopoulos NV, Agapitos E, Patsouris E (2004) Detection of cytomegalovirus, Helicobacter pylori and Chlamydia pneumoniae DNA in carotid atherosclerotic plaques by the polymerase chain reaction. Acta Cardiol 59:652-657
8. Ossewaarde JM, Feskens EJM, Vries A, Vallinga CE, Kromhout DK (1998) Chlamydia pneumoniae is a risk factor for coronary heart disease in symptom-free elderly men, but Helicobacter pylori and cytomegalovirus are not. Epidemiol Infect 120:93-99
9. Ramirez JA, and the Chlamydia pneumoniae/Atherosclerosis Study Group (1996) Isolation of Chlamydia pneumoniae from the coronary artery of patient with coronary atherosclerosis. Ann Intern Med 125:979-982
10. Ramires JA, Higuchi MD (2002) Mycoplasma pneumoniae and Chlamydia pneumoniae are associated to inflammation and rupture of the atherosclerotic coronary plaques. Rev Esp Cardiol 55(Suppl 1):2-9
11. Saikku P, Leinonen M, Mattila K, Nieminen MS, Huttunen JK, Ekman MR, Makela PH, Valtonen V (1988) Serological evidence of an association of a novel Chlamydia, TWAR, with chronic coronary heart disease and acute myocardial infraction. Lancet ii:983-986
12. Danesh JP, Whincup P, Walker M, Lennon L, Thomson A, Appleby P, Gallimore JR, Pepys MB (2000) Chlamydia pneumoniae IgG titers and coronary heart disease: prospective study and meta-analysis. Br Med J 321:208-213
13. Grayston JT (2000) Background and current knowledge of Chlamydia pneumoniae and atherosclerosis. J Infect Dis 181(Suppl 3):S402-S410
14. Leinonen M (2000) Chlamydia pneumoniae and other risk factors for atherosclerosis. J Infect Dis 181(Suppl 3):S414-S416
15. Blasi F, Fagetti L, Allegra L (2000) Chlamydia pneumoniae detection in atherosclerotic plaques in Italy. J Infect Dis 181(Suppl 3):S444-S446
16. Jackson LA, Campbell LA, Kuo CC, Rodriquez DI, Lee A, Grayston JT (1997) Isolation of Chlamydia pneumoniae from a carotid endarterectomy specimen. J Infect Dis 176:292-295
17. Kuo CC, Campbell LA (2000) Detection of Chlamydia pneumoniae in arterial tissue. J Infect Dis 181(Suppl 3):S432-S436
18. Maass M, Bartels SC, Engel PM, Momat U, Sievers HH (1998) Endovascular presence of viable Chlamydia pneumoniae is a common phenomenon in coronary artery disease. J Am Coll Cardiol 31:827-832
19. Fong I (2000) Antibiotic effects in a rabbit model of Chlamydia pneumoniae - induced atherosclerosis. J Infect Dis 181(Suppl 3):514-518
20. Fong I, Chiu B, Viira E, Fong MW, Jang D, Mahony J (1997) Rabbit model for Chlamydia pneumoniae infection. J Clin Microbiol 35:48-52
21. Moazed TC, Kuo CC, Grayston JT, Campbell LA (1997) Murine models of Chlamydia pneumoniae infection and atherosclerosis. J Infect Dis 175:883-890
22. Airenne S, Surcel HM, Alakarppa H, Laitinen K, Saikku P, Laurila A (1996) Chlamydia pneumoniae infection in human monocytes. Infect Immun 67:1445-1449
23. Gaydos CA, Summersgill JT, Sahney NN, Ramirez JA, Quinn TC (1996) Replication of Chlamydia pneumoniae in vitro in human macrophages, endothelial cells, and aortic artery smooth muscle cells. Infect Immun 64:1614-1620
24. Moazed TC, Kuo CC, Grayston JT, Campbell LA (1998) Evidence of systemic dissemination of Chlamydia pneumoniae via macrophages in the mouse. J Infect Dis 177:1322-1325
25. Yamaguchi H, Haranga S, Widen R, Friedman H, Yamamoto Y (2002) Chlamydia pneumoniae infection induces differentiation of monocytes into macrophages. Infect Immun 70:2392-2398
26. Blasi F, Boman I, Esposito G, Melissano G, Chielsa R, Cosentini R, Tarsia P, Tshomba Y, Betti M, Alessi M, Morelli N, Allegra L (1999) Chlamydia pneumoniae DNA detection in peripheral blood mononuclear cells is predictive of vascular infection. J Infect Dis 180:2074-2076
27. Boman J, Gaydos CA (2000) Polymerase chain reaction detection of Chlamydia pneumoniae in circulating white blood cells. J Infect Dis 181(Suppl 3):S452-S454
28. Boman J, Hammerschlag MR (2002) Chlamydia pneumoniae and atherosclerosis: critical assessment of diagnostic methods and relevance to treatment studies. Clin Microbiol Rev 15:1-20
29. Boman J, Soderberg S, Forsberg J, Birgander LS, Allard A, Persson K, Jidell E, Kumlin U, Juto P, Waldenstrom A, Wadell G (1998) High prevalence of Chlamydia pneumoniae DNA in peripheral blood mononuclear cells in patients with cardiovascular disease and in middle-aged blood donors. J Infect Dis 178:274-277
30. Maass M, Jahn J, Gieffers J, Dalhoff K, Katus HA, Solbach W (2000) Detection of Chlamydia pneumoniae within peripheral blood monocytes of patients with unstable angina or myocardial infraction. J Infect Dis 181(Suppl 3):S449-S451
31. Kishimoto T, Kubota Y, Matsushima T, Izutsu H, Matsumoto A, Soejima R, Morikawa T, Kawagoe K (1996) Assay of specific anti-Chlamydia pneumoniae antibodies by ELISA method. 1. Evaluation of ELISA kit using outer membrane complex. Kansenshogaku Zasshi 70:821-829
32. Kishimoto T, Kubota Y, Matsushima T, Izutsu H, Matsumoto A, Soejima R, Numazaki K, Chiba S, Yamazaki T, Sasaki N, Kaku M, Shimanda J, Iwasaki E, Baba M, Koori Y, Aihara M, Chikumi H, Kosaba S, Nonaka Y, Ouchi K, Yamamoto T, Kashiwagi S, Kawayama T, Ohizumi K, Nagai H (1996) Assay of specific anti-Chlamydia pneumoniae antibodies by ELISA method. 2: Studies on clinical usefulness and serological diagnostic standards. Kansenshogaku Zasshi 70:830-839
33. Tong CY, Sillis M (1993) Detection of Chlamydia pneumoniae and Chlamydia psittaci in sputum samples by PCR. J Clin Pathol 46:313-317
34. Campbell LA, O'Brien ER, Cappuccio AL, Kuo CC, Wang SP, Stewart DL, Patton PK, Cumming PK, Grayston JT (1995) Detection of Chlamydia pneumoniae TWAR in human coronary atherectomy tissues. J Infect Dis 172:585-588
35. Shor A, Kuo CC, Patton DL (1992) Detection of Chlamydia pneumoniae in coronary artery fatty streaks and atheromatous plaques. S Afr Med J 82:158-161
36. Sessa R, Di Pietro M, Schiavoni G, Nicoletti M, Soda G, Nardoni S, Bosco D, Santino I, Cipriani P, Del Piano M (2004) Detection of Chlamydia pneumoniae in atherosclerotic coronary arteries. Int J Immunopathol Pharmacol 17:301-306
37. Jantos CA, Nesseler A, Waas W, Baumgartner W, Tillmanns H, Haberbosh W (1999) Low prevalence of Chlamydia pneumoniae in atherectomy specimens from patients with coronary heart disease. Clin Infect Dis 28:988-992
38. Weiss SM, Roblin PM, Gaydos CA, Cummings P, Patton DL, Schulhoff N, Shani J, Frankel R, Penney K, Quinn TC, Hammerschlag MR, Schachter J (1996) Failure to detect Chlamydia pneumoniae in coronary atheromas of patients undergoing atherectomy. J Infect Dis 173:957-962
39. Paterson DL, Hall J, Rasmussen SJ, Timms P (1998) Failure to detect Chlamydia pneumoniae in atherosclerotic plaques of Australian patients. Pathology 30:169-172
40. Apfalter P, Blasi F, Boman J, Gaydos CA, Kundi M, Maass M, Makristathis A, Meijer A, Nadrchal R, Persson K, Rotter ML, Tong CYW, Stanek G, Hirschl AM (2001) Multicenter comparison trial of DNA extraction methods and PCR assays for detection of Chlamydia pneumoniae in endartectomy specimens. J Clin Microbiol 39:519-524
41. Gieffers J, van Zandbergen G, Rupp J, Sayk F, Kruger S, Ehlers S, Solbach W, Maass M (2004) Phagocytes transmit Chlamydia pneumoniae from the lungs to the vasculature. Eur Respir J 23:506-510
42. Gieffers J, Fullgraf H, Jahn J, Klinger M, Dalhoff K, Katus HA, Solbach W, Maass M (2001) Chlamydia pneumoniae infection in circulating human monocytes is refractory to antibiotic treatment. Circulation 103:351-356
43. Pantoja LG, Miller RD, Ramirez JA, Molestina RE, Summersgill JT (2000) Inhibition of Chlamydia pneumoniae replication in human aortic smooth muscle cells by γ interferon-induced indoleamine 2,3-dioxygenase activity. Infect Immun 68:6478-6481
44. Gieffers J, Durling L, Ouellette SP, Rupp J, Maass M, Byrne GI, Caldwell HD, Belland RJ (2003) Genotypic differences in the Chlamydia pneumoniae tyrP locus related to vascular tropism and pathogenicity. J Infect Dis 188:1085-1093
45. Cochrane M, Pospischil A, Walker P, Gibbs H, Timms P (2005) Discordant detection of Chlamydia pneumoniae in patients with carotid artery disease using polymerase chain reaction, immunofluorescence microscopy and serological methods. Pathology 37:69-75
46. Freidank HM, Billing H, Wiedmann-Al-Ahmad M (2001) Influence of iron restriction on Chlamydia pneumoniae and C trachomatis. J Med Microbiol 50:223-227
47. Karvonen M, Tuomilehto J, Pitkaniemi J, Naukkarinen A, Saikku P (1994) Importance of smoking for Chlamydia pneumoniae seropositivity. Int J Epidemiol 23:1315-1321